CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $207,000 | -21.3% | 8,375 | -6.4% | 0.00% | -50.0% |
| Q3 2018 | $263,000 | -46.9% | 8,945 | -18.5% | 0.00% | -50.0% |
| Q2 2018 | $495,000 | +121.0% | 10,970 | +38.9% | 0.00% | +100.0% |
| Q1 2018 | $224,000 | +12.0% | 7,897 | +119.9% | 0.00% | 0.0% |
| Q3 2017 | $200,000 | -47.1% | 3,591 | -27.1% | 0.00% | -33.3% |
| Q2 2017 | $378,000 | -36.8% | 4,929 | -70.4% | 0.00% | -57.1% |
| Q3 2016 | $598,000 | +200.5% | 16,625 | +59.5% | 0.01% | +600.0% |
| Q1 2016 | $199,000 | -31.8% | 10,425 | +25.6% | 0.00% | -66.7% |
| Q4 2015 | $292,000 | -29.6% | 8,300 | +84.2% | 0.00% | -40.0% |
| Q3 2015 | $415,000 | +38.3% | 4,507 | +32.3% | 0.01% | 0.0% |
| Q2 2015 | $300,000 | – | 3,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |